In Vitro Fertilization: Clinical Trials

5 trials for In Vitro Fertilization, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5

Follow In Vitro Fertilization: new trials by email Literature Review of In Vitro Fertilization trials Research Report on In Vitro Fertilization

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparing the Efficacy of Urinary and Recombinant Human Chorionic Gonadotropin (hCG) on Oocyte Maturity
recombinant hCG, urinary hCG - In Vitro Fertilization
Phase 3CompletedRoyan Institute1802010-10-012014-04-25
Subcutaneous Progesterone Versus Vaginal Progesterone Gel for Luteal Phase Support in Patients Undergoing In-Vitro Fertilization (IVF)
Progesterone - In Vitro Fertilization
Phase 3CompletedIBSA Institut Biochimique SA6832009-01-012013-01-31
Subcutaneous Progesterone Versus Vaginal Progesterone Tablets for Luteal Phase Support in In Vitro Fertilization (IVF)
Progesterone - In Vitro Fertilization
Phase 3CompletedIBSA Institut Biochimique SA8002008-12-012013-01-31
Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)
Corifollitropin alfa, FSH, GnRH antagonist - In Vitro Fertilization
Phase 3CompletedOrganon and Co6822006-09-262024-06-18
A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)
Corifollitropin alfa, RecFSH / Follitropin beta (Days 1 to 7), Placebo Corifollitropin alfa - In Vitro Fertilization
Phase 3CompletedOrganon and Co15092006-06-272024-06-20

Narrower conditions

Infertility (2)

Broader conditions

Genital Diseases (2)  ·  Urogenital Diseases (2)

Interventions

Progesterone (4)  ·  Chorionic Gonadotropin (2)  ·  follicle stimulating hormone, human, with HCG C-terminal peptide (2)  ·  Glycoprotein Hormones, alpha Subunit (1)  ·  LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (1)  ·  follitropin beta (1)  ·  ganirelix (1)

Sponsors

IBSA Institut Biochimique SA (2)  ·  Organon and Co (2)  ·  Royan Institute (1)

Countries

Germany (1)  ·  Hungary (1)  ·  Iran (1)  ·  Italy (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Hamid Gourabi, PhD (1)  ·  Taraneh Madani, MD (1)

Results publications

PMID 26950065, PMID 26991902, PMID 30895243, PMID 19684043, PMID 20843746, PMID 21622693, PMID 23274511, PMID 23758821, PMID 24140033, PMID 24903202, PMID 25100106, PMID 26187300, PMID 27619773

NIH funding

2004 (2)